...
机译:唇癌:重新考虑有病理评估的风险患者
Department of Otorhinolaryngology Head and Neck SurgeryAnkara A.Y. Oncology Education and Research;
Department of Otorhinolaryngology Head and Neck SurgeryAnkara A.Y. Oncology Education and Research;
Department of Plastic and Reconstructive SurgeryAnkara A.Y. Oncology Education and Research;
Department of Otorhinolaryngology Head and Neck SurgeryAnkara A.Y. Oncology Education and Research;
Department of Otorhinolaryngology Head and Neck SurgeryAnkara A.Y. Oncology Education and Research;
Department of Otorhinolaryngology Head and Neck SurgeryAnkara A.Y. Oncology Education and Research;
Department of PathologyAnkara A.Y. Oncology Education and Research HospitalAnkara Turkey;
cancer; lip; lymph node metastases; pathology; recurrence;
机译:唇癌:重新考虑有病理评估的风险患者
机译:淋巴结阴性乳腺癌病理评估中观察者间差异对临床辅助评估的临床风险评估和患者选择的影响
机译:三阴性乳腺癌:在新辅助化疗期间使用18F-FDG PET / CT进行的早期评估可确定不太可能实现病理完全缓解且极有可能复发的患者。
机译:前列腺活检指导错误如何影响病理性癌症风险评估?
机译:在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
机译:PSIM(前列腺全身炎症标志物)评估在低风险前列腺癌患者中达到主动监测纳入标准的低危前列腺癌患者中的病理特征评价
机译:PSIM(前列腺全身炎症标志物)评估在低风险前列腺癌患者中达到主动监测纳入标准的低危前列腺癌患者中的病理特征评价